who should not use semaglutide for weight loss Shines as Therapy Why Am I Not Losing

Objective Monitoring: Periodic laboratory testing may be recommended for certain individuals, particularly those with pre-existing health conditions or those following intensive protocols

Here is the concern

Tirzepatide, as Zepbound, is FDA-approved to treat OSA in adults with obesity

Injectable forms provide more systemic effects, while oral capsules focus on gastrointestinal issues, with typical professional dosing at 250-500 mcg daily for 4-6 weeks

Taking high-dose selenium supplements has been shown to potentially have anti-cancer effects

Paired t -tests or Wilcoxon signed-rank tests were used to compare baseline (T0) and 6-month (T6) values and between T6 and 12 months extension period (T12), depending on normality